Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Translational Oncology
|
June 7, 2023
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
Vatsala Mundra, Yuqiu Yang, Mitchell S von Itzstein, et al.
Nature Medicine
|
April 15, 2022
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Edward S Kim, Vamsidhar Velcheti, Tarek Mekhail, et al.
British Journal of Cancer
|
October 16, 2018
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
David E Gerber, M Shaalan Beg, Farjana Fattah, et al.
Clinical Lung Cancer
|
July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
Cancers
|
March 10, 2022
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy
Mitchell S von Itzstein, Amrit S Gonugunta, Thomas Sheffield, et al.
Molecular Cancer Therapeutics
|
August 11, 2021
Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway
Wei Zhang, Ankur S Bhagwath, Zeeshan Ramzan, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data
Bing Song, Kaiwen Wang, Saiyang Na, et al.
JTO Clinical and Research Reports
|
August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
William Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
Margaret Stalker, Connor B Grady, Alex Watts, et al.
Nature Cancer
|
June 27, 2025
Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes
Bing Song, Kaiwen Wang, Saiyang Na, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Translational Oncology
|
June 7, 2023
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
Vatsala Mundra, Yuqiu Yang, Mitchell S von Itzstein, et al.
Nature Medicine
|
April 15, 2022
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Edward S Kim, Vamsidhar Velcheti, Tarek Mekhail, et al.
British Journal of Cancer
|
October 16, 2018
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
David E Gerber, M Shaalan Beg, Farjana Fattah, et al.
Clinical Lung Cancer
|
July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
Cancers
|
March 10, 2022
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy
Mitchell S von Itzstein, Amrit S Gonugunta, Thomas Sheffield, et al.
Molecular Cancer Therapeutics
|
August 11, 2021
Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway
Wei Zhang, Ankur S Bhagwath, Zeeshan Ramzan, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data
Bing Song, Kaiwen Wang, Saiyang Na, et al.
JTO Clinical and Research Reports
|
August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
William Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
Margaret Stalker, Connor B Grady, Alex Watts, et al.
Nature Cancer
|
June 27, 2025
Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes
Bing Song, Kaiwen Wang, Saiyang Na, et al.
Page
of 6